Related Experiment Video
Updated: May 28, 2026

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
Published on: January 28, 2014
Biomarkers and heart disease.
1Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA. maalbert@partners.org
This review evaluates biomarkers and surrogate endpoints for chronic disease risk, particularly cardiovascular disease. It highlights their utility in sleep research and clinical practice, offering a framework for biomarker assessment.
Area of Science:
- Biomedical Science
- Clinical Research
- Cardiovascular Medicine
Background:
- Chronic diseases, including cardiovascular disease, pose significant public health challenges.
- Biomarkers and surrogate endpoints are crucial for assessing disease risk and treatment efficacy.
- The Institute of Medicine (IOM) Committee on Qualification of Biomarkers and Surrogate Endpoints in Chronic Disease has provided foundational work.
Purpose of the Study:
- To review the evaluation of biomarkers and surrogate endpoints in chronic disease risk.
- To focus specifically on the application and evaluation within cardiovascular disease research.
- To illustrate the potential use of biomarkers in sleep research and clinical settings.
Main Methods:
- Literature review and synthesis of existing research on biomarkers and surrogate endpoints.
- Analysis of the IOM committee's framework for biomarker qualification.
- Case study analysis of representative biomarkers in chronic disease.
Main Results:
- Biomarkers and surrogate endpoints require rigorous evaluation for reliable use in clinical practice.
- A structured framework aids in assessing the validity and utility of potential biomarkers.
- Specific examples demonstrate the impact of well-qualified biomarkers on disease research and patient care.
Conclusions:
- Effective evaluation frameworks are essential for qualifying biomarkers and surrogate endpoints.
- Biomarkers hold significant promise for improving risk prediction and management of chronic diseases, including cardiovascular conditions.
- Further research and standardized evaluation are needed to fully leverage biomarkers in sleep research and clinical decision-making.
Related Concept Videos
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Acute Coronary Syndrome III: Diagnostic Studies
Coronary Artery Disease I: Introduction
Dysrhythmias V: Evaluating Dysrhythmias
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
